An interventional study of Repair of the annulus fibrosus in Lumbar Intervertebral Disc Herniation, sponsored by The Affiliated Hospital of Qingdao University. Recruiting at 1 site in China. Open to participants aged 12 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-11-26.
Sponsored by The Affiliated Hospital of Qingdao University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Intervertebral Disc Displacement with a site in China — 13 open to participants now, 14 under way, none of them phase 3. Intervertebral Disc Displacement · China.
Among the 52 studies in Intervertebral Disc Displacement with a site in China, this one is the 2nd largest by planned enrollment of the 41 interventional ones that give a count, is one of 6 that started in 2025, is one of 35 with no phase, reaches primary completion later than 5 of the 13 other live ones, and was the 43rd registered.
474 studies on the registry are indexed under Intervertebral Disc Displacement; 98 are open to participants now.
Browse Intervertebral Disc Displacement studies →13 of the 52 studies in Intervertebral Disc Displacement with a site in China are open now. Recruiting first, the newest first:
Fan Zhang · Sites in China
Ages 18–75
Li Xiang · Sites in China
Ages 19–65
Peking University Third Hospital · Sites in China
Ages 18–80
The Third Affiliated hospital of Zhejiang Chinese Medical University · Sites in China
Ages 20–60 · Healthy volunteers
Beijing Jishuitan Hospital · Sites in China
Ages 18–85
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 48 Intervertebral Disc Displacement studies recruiting now, 20 (42%) set no upper age limit and 24 (50%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.
This study: 12 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 6 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 63 across 344 interventional studies indexed under Intervertebral Disc Displacement.
Median enrollment 90 across the 41 interventional studies, 120 across the 11 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 52 has an industry lead sponsor. The 10 most frequent:
The Affiliated Hospital of Qingdao University is the lead sponsor of 151 studies on the registry; 56 are open to participants now.
The Affiliated Hospital of Qingdao University has 2 studies filed under Intervertebral Disc Displacement — fewer than ten, so there is no comparison to draw.
5 of the studies in Intervertebral Disc Displacement with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07161232Li XiangThe Influence of the Timing of Postoperative Rehabilitation Intervention on the Clinical Efficacy of Unilateral Biportal Endoscopic Spine System in the Treatment of Lumbar Disc Herniation | 2026-11-28 |
| NCT07531485Xi'an Honghui HospitalThe Selective Intraperineural Nerve Root Block Study | 2026-12-01 |
| NCT07250581The Affiliated Hospital of Qingdao UniversityA Randomized Trial of Annular Repair With Discectomy Versus Discectomy Alone for Lumbar Disc Herniation | 2026-12-31 |
| NCT07728149The Third Affiliated hospital of Zhejiang Chinese Medical UniversityBrain Connectomic Mechanisms of Spinal Manipulative Therapy on LDH Analgesia Based on Multimodal MRI | 2027-09 |
| NCT06591442Wuhan Union Hospital, ChinaScreening and Prospective Cohort Study of Risk Factors for Enhanced Recovery After Spinal Fusion Surgery in Advanced Age Patient | 2027-09-03 |
Add all 5 to your calendar (.ics) → With an account.
Among the 52 studies in Intervertebral Disc Displacement with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study is to explore the indications and application scope of spinal endoscopy combined with annulus fibrosus repair technology, with a focus on verifying the effectiveness of annulus fibrosus suture technology and evaluating its safety, so as to further support the promotion of annulus fibrosus repair technology in patients with lumbar disc herniation.
Background Lumbar Disc Herniation (LDH) is a significant clinical and public health issue, particularly due to its high incidence and impact on working-age populations. It is a leading cause of non-fatal health loss globally. While conservative management is first-line, surgery is indicated for refractory cases. Among surgical options, endoscopic discectomy has emerged as a superior minimally invasive technique, offering advantages like minimal trauma, rapid recovery, and preserved spinal stability compared to open surgery or fusion.
However, a key limitation of standard endoscopic discectomy is the residual defect in the annulus fibrosus (AF) after nucleus pulposus removal. This defect is a significant risk factor for postoperative recurrence, as residual disc material can re-herniate. Larger defects (≥6mm) are associated with significantly higher recurrence and reoperation rates. Annulus repair techniques, initially attempted in open surgery with limited success due to extensive tissue disruption, hold renewed promise in the minimally invasive endoscopic context. The recent development of dedicated endoscopic AF suture devices in China enables precise repair through the endoscope, potentially reducing recurrence and postoperative neural complications by restoring AF integrity, minimizing scar adhesion, and containing inflammatory mediators.
Preliminary clinical application of this AF suture technique in over 12,000 cases suggests it adds only minimal time (\~8 minutes) to the procedure while offering significant potential benefits. This study aims to rigorously evaluate the safety and efficacy of endoscopic discectomy combined with AF repair versus discectomy alone through a prospective, multicenter, randomized controlled trial (RCT).
Study Objectives and Significance Primary Objectives:To evaluate the efficacy of AF repair in reducing the postoperative recurrence rate of LDH.To assess the safety of AF repair by comparing perioperative complications and early postoperative pain exacerbation between the suture and control groups.
Significance:This study will provide high-quality, multicenter RCT data to clarify the indications, technical nuances, clinical outcomes, and recurrence prevention effect of endoscopic AF suture. The findings will support the standardization and scientific application of this promising technology, offering valuable evidence for clinicians and patients in selecting optimal treatment strategies, particularly for young and active patients seeking rapid recovery and long-term durability.
Inclusion Criteria:
Age 12-65, any gender. Confirmed diagnosis of LDH. Non-calcified herniation type. Preoperative MRI shows Pfirrmann grade I-II disc degeneration. Failure of ≥6 months conservative treatment with significant impact on quality of life.
Willing and able to provide informed consent and comply with long-term follow-up.
Exclusion Criteria:
Concomitant lumbar spondylolisthesis, instability, or other significant spinal pathologies.
Previous lumbar spine surgery. Major systemic diseases contraindicating surgery. Conditions potentially affecting healing (e.g., malnutrition, bone metabolic diseases, autoimmune diseases).
Inability to adhere to follow-up schedule.
Intervention and Groups:Eligible patients will be randomly assigned to one of two groups:
Intervention Group: Endoscopic Discectomy + Annulus Fibrosus Repair. Control Group: Endoscopic Discectomy alone. Randomization: Randomization will be performed using PASS 11.0 generated random sequence after informed consent and baseline assessment, based on order of enrollment.
Outcome Measures:
Primary Outcomes:
Surgical success rate (successful completion of AF suture). Recurrence rate (re-herniation at the operated level) at short-term and long-term follow-up.
Postoperative efficacy: assessed by Visual Analog Scale (VAS) for back/leg pain, Japanese Orthopaedic Association (JOA) score, and Oswestry Disability Index (ODI).
Reoperation rate. Postoperative inflammatory markers (e.g., CRP, Procalcitonin).
Secondary Outcomes:
Incidence of nerve injury (sensory/motor). Incidence of bleeding/hematoma. Overall complication rate (e.g., infection, dural tear). Postoperative infection rate.
Data Collection and Follow-up:
Data collected includes demographic details, perioperative parameters (surgical level, time, blood loss, hospital stay), clinical scores (VAS, ODI, JOA), imaging data (herniation size, AF defect size, spinal canal area), and laboratory tests. Follow-up assessments are scheduled at 1, 3, 6, and 12 months postoperatively. Imaging follow-up includes MRI at 3 months, CT at 6 months, and both CT/MRI at 12 months.
Statistical Analysis:
Data will be managed using an Electronic Data Capture (EDC) system and analyzed with SPSS 25.0. Appropriate descriptive statistics will be used. Group comparisons for continuous variables will use t-tests or Mann-Whitney U tests, and chi-square tests for categorical variables. Repeated Measures ANOVA will analyze longitudinal data. Missing data will be handled with appropriate imputation methods and sensitivity analysis. A significance level of α=0.05 (two-sided) will be used.
Sample Size Calculation:
Based on an assumed recurrence rate of 5% in the control group and 2.4% in the intervention group, with α=0.05 and 90% power, a sample size of 224 is required. Accounting for a potential 20% dropout rate, the total target sample size is 300 patients. The lead center (Qingdao University Affiliated Hospital) will contribute approximately 100 patients.
Participating Centers (Multicenter):
The study involves one primary center and nine participating centers across China, each led by a principal investigator:
Primary Center: The Affiliated Hospital of Qingdao University. Participating Centers: Include Qilu Hospital of Shandong University, Shandong Provincial Hospital, Peking Union Medical College Hospital, The First Affiliated Hospital of Harbin Medical University, The First Affiliated Hospital of Wenzhou Medical University, The Third Xiangya Hospital of Central South University, The Second Affiliated Hospital of Xi'an Jiaotong University, The Fourth Affiliated Hospital of Zhejiang University School of Medicine, among others.
Ethics and Quality Control:
The protocol will be submitted for ethical approval at each center. Investigators will receive standardized training on the AF suture technique and data management procedures. Data integrity, accuracy, and confidentiality will be ensured through rigorous quality control measures, including training, data validation rules, double data entry checks, and secure handling of identifiable information.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Annulus fibrosus repair, Suture the incision of the annulus fibrosus
Procedure: Repair of the annulus fibrosus
Non-annulus fibrosus repair, Do not suture the incision of the annulus fibrosus
Suture the incision of the annulus fibrosus
Recurrence rate
The proportion of lumbar intervertebral disc protrusion recurring at the surgical segment within a certain period after surgery, including short-term recurrence and long-term recurrence.
Time frame: Within one year
Postoperative therapeutic effect
The change of the quality of life of postoperative patients was evaluated by using the VAS(Visual Analog Score), Zero to ten points indicates the degree of pain from mild to severe
Time frame: Within one year
Postoperative therapeutic effect
The change of the quality of life of postoperative patients was evaluated by using the JOA score(Japanese Orthopaedic Association), In the JOA score, a range from 0 to 29 points is interpreted as indicating a progression from poor to good.
Time frame: Within one year
Postoperative therapeutic effect
The change of the quality of life of postoperative patients was evaluated by using the ODI (Oswestry Disability Index), 0% represents the least severe condition, while 100% indicates the most severe condition.
Time frame: Within one year
Nerve injury
The proportion of postoperative nerve injury, including cases of sensory and motor nerve injury.
Time frame: Within one year
PDFs hosted by the registry, ClinicalTrials.gov.
Started Aug 2025 (actual). Primary completion is estimated for Dec 2026, 16 months after the start.
Of 178 non-industry interventional studies with no phase under Intervertebral Disc Displacement, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 16 months is above that.
Counting every sponsor, half of 191 studies reached it within 12 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Intervertebral Disc Displacement →
The Affiliated Hospital of Qingdao University →